Cannabis Use and Fetal Growth in Pregnant Women with Diabetes
ACOG ePoster. Hamilton O. Apr 27, 2018; 211573; 18L
Owen Hamilton
Owen Hamilton
Login now to access Regular content available to all registered users.

You may also access this content "anytime, anywhere" with the Free MULTILEARNING App for iOS and Android
Abstract
Rate & Comment (0)
Introduction: Cannabis use during pregnancy is associated with lower birth weight, but little is known about the impact of prenatal cannabis use in women with co-morbidities. Our objective was to examine the association between cannabis use and birthweight in women with pre-existing and gestational diabetes.

Methods: We performed a retrospective cohort study at the Center for Diabetes and Pregnancy at Barnes Jewish Hospital from 2012-2016. Women who self-reported cannabis use or had positive maternal or infant drug screens for cannabinoids were compared with those who did not. The primary outcome was large for gestational age (LGA) defined as birthweight 90th%. Secondary outcomes were mean birthweight and small for gestational age (SGA, birthweight
    This eLearning portal is powered by:
    This eLearning portal is powered by MULTIEPORTAL
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.


Save Settings